Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) by Jaglowski, Samantha M., MD, MPH, Jones, Jeffrey A., MD, MPH, Flynn, Joseph M., DO, MPH, Andritsos, Leslie A., MD, Maddocks, Kami J., MD, Woyach, Jennifer A., MD, Blum, Kristie A., MD, Grever, Michael R., MD, Geyer, Susan Michelle, PhD, Heerema, Nyla A., PhD, Lozanski, Gerard, MD, Stefanos, Mona, BS, Hall, Nathan, MD, PhD, Nagar, Veena, MD, Munneke, Brian, PhD, West, Jamie-Sue, Neuenburg, Jutta K., MD, PhD, James, Danelle F., MD, MAS, Johnson, Amy J., PhD, Byrd, John C., MD

Get full text